Cargando…
Overexpression of GATA5 Stimulates Paclitaxel to Inhibit Malignant Behaviors of Hepatocellular Carcinoma Cells
OBJECTIVE: Explore the effect of GATA5 expression on Paclitaxel inhibiting growth of hepatocellular carcinoma (HCC) cells. MATERIALS AND METHODS: In the experimental study, HCC cell lines (HLE, Bel7402 and PLC/PRF/5) were treated with different concentrations of Paclitaxel (5-20 mg/ml) for 24 hours....
Autores principales: | Feng, Haipeng, Lin, Bo, Zheng, Yifei, Xu, Junnv, Zhou, Ying, Liu, Kun, Zhu, Mingyue, Li, Mengsen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Royan Institute
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481888/ https://www.ncbi.nlm.nih.gov/pubmed/32779438 http://dx.doi.org/10.22074/cellj.2020.6894 |
Ejemplares similares
-
GATA5 inhibits hepatocellular carcinoma cells malignant behaviours by blocking expression of reprogramming genes
por: Feng, Haipeng, et al.
Publicado: (2019) -
IL-6/STAT3 Is a Promising Therapeutic Target for Hepatocellular Carcinoma
por: Xu, Junnv, et al.
Publicado: (2021) -
Alpha fetoprotein antagonises benzyl isothiocyanate inhibition of the malignant behaviors of hepatocellular carcinoma cells
por: Zhu, Mingyue, et al.
Publicado: (2016) -
Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells
por: Zhang, Minni, et al.
Publicado: (2023) -
α‐Fetoprotein fragment synergizes with sorafenib to inhibit hepatoma cell growth and migration and promote the apoptosis
por: Wang, Qiujiao, et al.
Publicado: (2022)